Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 2010. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of insider share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary shares by seven individuals on November 9, 2010, at a price of £12.45 per share through the Company's Share Reward Plan. The transactions involved both personal contributions and company matching contributions.
- Mr A P Witty: Acquired 10 shares (personal) and 10 shares (company match).
- Mr J S Heslop: Acquired 10 shares (personal) and 10 shares (company match).
- Mr S M Bicknell: Acquired 10 shares (personal) and 10 shares (company match).
- Mr E J Gray: Acquired 10 shares (personal) and 10 shares (company match).
- Mr D S Redfern: Acquired 10 shares (personal) and 10 shares (company match).
- Ms C Thomas: Acquired 10 shares (personal) and 10 shares (company match).
- Mr P J T Vallance: Acquired 10 shares (company match) and 10 shares (personal).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share transactions described above in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Share price for the transaction was £12.45 per Ordinary share.
- Transactions occurred on November 9, 2010, and were notified on November 10, 2010.
- Seven senior individuals participated in the Share Reward Plan.
- The filing contains no financial performance metrics or strategic outlook.